Henderson Daxin (002492): Foreign Investment Rating Report (Overseas Institutional Investment Rating D)
[Anxin Securities] Henderson Daxin: Weigao Orthopedics plans to take the lead in orthopedic devices in China
Hengji Daxin (002492) in-depth analysis: Weigao Orthopaedics intends to use the shell to return to the leading orthopedic instruments in China.
Hengji Daxin (002492) comments: cost rigidity drags down performance Venture Capital and Transformation actively promote
Hengji Daxin (002492) briefing: petrochemical warehousing industry hit bottom, M & A space can be expected.
[Shenyin Wanguo Securities] Hengji Daxin's third quarterly report comments: the performance is in line with expectations, and the Yangzhou and Wuhan projects are making steady progress.
[Shenyin Wanguo Securities] Hengji Daxin follow-up report: the company has been invested by Luxin Venture Capital, and the transformation will be more smooth.
[Shenyin Wanguo Securities] Hengji Daxin follow-up report: further transformation to LNG logistics, reiterate "increasing holdings"
[Hongyuan Securities] Hengji Daxin: signing the cooperation agreement, new progress has been made in the field of LNG
Hengji Daxin (002492): benefit from oil reform policy dividend issue to expand industrial chain
【申银万国证券】恒基达鑫-融资预案点评:理顺高管与大股东利益机制,助力公司拓展产业链
【兴业证券】恒基达鑫:非公开发行助力异地多元化扩张
恒基达鑫(002492):非公开发行助力异地多元化扩张
【宏源证券】恒基达鑫:意向拓展LNG,进军清洁能源领域
恒基达鑫(002492)公司动态跟踪报告:意向拓展LNG 进军清洁能源领域
【爱建证券】恒基达鑫:重资产模式下租客减少,未来区位调整与产业链延伸是看点
恒基达鑫 (002492):收购股权点评:收购项目拓展公司网点及业务市场 有利于提升
【申银万国证券】恒基达鑫:收购项目拓展公司网点及业务市场,有利于提升ROE
恒基达鑫(002492)2013年年报点评:竞争加剧 业绩下滑
【兴业证券】恒基达鑫:业绩仍处于低谷,高送转助长期发展
No Data